The review found no consistent evidence that depression is associated with, or caused by, lower serotonin concentrations or activity. It also concluded that the large research effort behind the serotonin hypothesis has not produced convincing biochemical evidence for depression and suggested that the theory is not empirically substantiated.

The article states that there is 'no compelling evidence' that depression is caused by low serotonin. It also notes that the serotonin story has long been presented as a simple chemical-imbalance explanation, but the research evidence does not support that account.

The article says the monoamine hypothesis is inadequate in its original form and that the pathophysiology of depression remains unknown. It also notes that the hypothesis does not explain key issues such as delayed antidepressant response or why not all drugs that increase serotonergic or noradrenergic transmission are effective in depression.

The abstract reports that a review of the scientific literature found a disconnect between popular claims and evidence about serotonin and depression. It concludes that most research does not support the idea that depression is caused by low serotonin levels.

The chapter states that attempts to directly measure brain monoamine changes in mood disorders have produced intriguing but inconsistent results. It also says that several findings are difficult to reconcile with the monoamine hypothesis, including the delayed onset of antidepressant effects despite immediate biochemical changes.

WHO describes depression as a complex mental disorder and does not present a single neurotransmitter change as established causal evidence. Its fact sheet emphasizes that depression results from a combination of social, psychological and biological factors, with no simple biological explanation given as definitive cause.

NIMH describes depression as a serious but common illness and notes that its exact causes are not fully understood. The page presents multiple contributing factors rather than confirming that depression is caused by neurotransmitter changes alone.

The traditional explanation of the pathogenesis of depression, centered on the imbalance of brain neurotransmitters (serotonin in the first place), is now judged unsatisfactory and still widely debated in the scientific community.[6] The low effectiveness of antidepressants that enhance the intrasynaptic availability of serotonin and other neurotransmitters cannot therefore prove that the cause of depression is a deficiency of these molecules.[6] In addition, a systematic umbrella review, which examined the major areas of research regarding the hypothesis that serotonin is deficient during depression, found no evidence that brain deficiency or low activity of the neurotransmitter is at the root of the psychiatric disorder.[6]

UCL Psychiatry says its research review found no clear evidence that serotonin levels or serotonin activity are responsible for depression. It adds that studies comparing serotonin measures in depressed and non-depressed people did not show a consistent difference.

Harvard Health states that depression does not arise from simply having too much or too little of certain brain chemicals. It says chemicals are involved, but the cause is not a simple one-chemical chemical-imbalance explanation.

After decades of study, there remains no clear evidence that serotonin levels or serotonin activity are responsible for depression, according to a major review of prior research led by UCL scientists.[2] Lead author Professor Joanna Moncrieff said: “we can safely say that after a vast amount of research conducted over several decades, there is no convincing evidence that depression is caused by serotonin abnormalities, particularly by lower levels or reduced activity of serotonin.”[2] These findings together led the authors to conclude that there is “no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.”[2]

Researchers now believe that depression is not simply the result of either too much or too little of certain brain chemicals.[9] Instead, there are many possible causes of depression, including faulty mood regulation by the brain, genetic vulnerability, and stressful life events, as well as medical problems and medications.[9] The idea that depression stems from a simple chemical imbalance in the brain has lost favor; the condition appears to involve complex interactions among neurotransmitters, hormones, and neural circuits.[9]

For decades, those diagnosed with depression have been told they suffer from a 'chemical imbalance.' This explanation involves neurotransmitters, such as serotonin, thought to be the main neurochemical responsible for major depressive disorders. Growing research challenges this theory and the need for medication therapies for depressive symptoms. This brief summarizes new findings examining the theory that depression is caused by a chemical imbalance and calls for healthcare professionals and patients to consider the market influences and social structures that impact health.

Yale Medicine says that for decades scientists thought the primary cause of depression was an abnormality in neurotransmitters such as serotonin or norepinephrine, but that this limited hypothesis did not account well for major depression symptoms. It points to other neurotransmitters and brain systems as alternative explanations.

The biochemical alterations in neurotransmitters associated with major depressive disorder (MDD) remain largely elusive.[4] Patients newly diagnosed with depression who had not received treatment exhibited atypical neurotransmitter profiles, and key factors associated with MDD included glutamate, GABA, dopamine-related markers and others as risk factors, while kynurenine served as a protective factor.[4] Recent studies have highlighted that dysfunctional neurotransmitter metabolism significantly influences the pathophysiology of depression, although specific causal mechanisms are still not clearly defined.[4]

The theory that depression is caused by a serotonin abnormality or other chemical imbalance has become widely accepted by the public. However, experts have increasingly challenged the evidence base for this theory, describing it as an 'urban legend' rather than a scientifically established fact. The article explores how this notion of a chemical imbalance in depression persists in public discourse despite the lack of strong scientific support.

Yale Medicine explains that depression involves neurotransmitters, but serotonin and norepinephrine did not seem to account for the symptoms associated with major depression. The article frames neurotransmitter changes as part of a broader neurobiology rather than a complete explanation.

According to surveys, more than 4 in 5 people believe that depression stems from imbalanced brain chemicals and, specifically, to low levels of serotonin. Psychiatric experts, however, say that this understanding of depression was disproven long ago. The dissonance between the public's understanding of depression and the psychiatric literature came to a head recently when British psychiatrist Dr. Joanna Moncrieff, co-author Mark Horowitz and colleagues published an extensive review of existing studies in July and put the final nail in the coffin on the serotonin theory.

This review describes the monoamine-deficiency theory, but also notes that the delayed onset of antidepressant action and drug resistance suggest that monoaminergic dysfunction may be downstream of other primary abnormalities. The paper discusses additional evidence for glutamate-system dysfunction, showing that depression biology is broader than a simple neurotransmitter-deficit model.

The page explains that the monoamine hypothesis proposed monoamine levels have a primary role in causing depression, but it also notes that this framework is only one explanation and introduces a section on evidence for the hypothesis. It presents the theory as an influential historical model rather than a settled scientific conclusion.

A study published in a 2023 issue of the journal Molecular Psychiatry found further reason to doubt this explanation. The research indicated there is little evidence to suggest that depression is caused by chemical imbalances in the brain.[7] The chemical theory of depression suggested that imbalances in brain chemistry were a primary cause of depression. However, recent findings found no evidence to support this idea.[7] This suggests that depression is caused by complex factors, including environmental variables, and cannot be reduced to simply a chemical imbalance in the brain.[7]

The chemical imbalance theory is that depression correlates with low levels of neurotransmitters called serotonin and norepinephrine. However, recent scientific evidence has failed to prove this theory. The only evidence is that people with depression have fewer neurotransmitters in their blood, and depression symptoms are relieved in some patients through medications that increase neurotransmitters. These findings are not always consistent and may not explain the underlying biology of depression. In reality, what causes depression is much more complicated than an imbalance of chemicals.

The article says that studies of monoamine levels in the brain and their correlation with depression symptoms were inconclusive. It also states that most mental health experts came to see the monoamine hypothesis as inadequate, even if it was useful for explaining depression to patients.

The dissertation argues that based on magnetic resonance spectroscopy and laboratory findings, other systems such as GABA may be intimately involved in depression. That framing is consistent with the idea that monoamine decline alone does not fully explain depressive illness.

The article refers to the monoamine-decline model as the widely accepted current hypothesis for depression, while discussing newer alternative hypotheses. This indicates the field has moved beyond a single-neurotransmitter explanation and is actively comparing competing models.

Modern research shows that there is no consistent evidence linking low serotonin to depression and that depression is a multifaceted condition. If depression is caused by low serotonin, these measures should consistently show deficits in depressed individuals, yet the evidence shows that this isn’t the case. A large-scale comprehensive review of the evidence, synthesizing decades of data, found no consistent evidence that depression is associated with reduced serotonin levels or activity, generating much discussion and commentary. The 'chemical imbalance' theory of depression, and in particular the idea that it is caused by low serotonin, was a historically influential but oversimplified model.

Despite 85–90% of people believing that depression is caused by a chemical imbalance, there is no evidence that a chemical imbalance causes depression or is associated with depression. A new meta-analysis by the University College London reviewed the evidence and made headlines this week. They summarized their research by saying there's no consistent evidence of there being an association between serotonin and depression and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.

The monoamine hypothesis was historically influential, but modern reviews generally treat it as incomplete rather than a proven full explanation for depression. Contemporary research emphasizes that depression is multifactorial and that no single neurotransmitter abnormality has been established as sufficient to explain all cases.

Commenters discussing the review note that “serotonin deficiency = depression has been understood to not be the primary mechanism for some time.”[3] One summary in the thread states that the review shows “depression isn't explained simply by a low level of serotonin – psychiatrists and scientists already knew this,” emphasizing that depression is caused by more than one factor and that serotonin is not a root cause.[3] The discussion reflects a broader shift away from explaining depression solely as a neurotransmitter imbalance.[3]

The video explains that studies have failed to consistently find reduced serotonin activity in people with depression, and that tryptophan-depletion experiments have not reliably produced depressed mood. It also says serotonin is at best only part of the story in explaining depression.